FDA approves drug to treat ALS - FDA Press Releases

The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease.

from Food and Drug Administration--Press Releases http://ift.tt/2piqApw
via IFTTT